Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cullinan Therapeutics, Inc. CGEM

Set alert

Price alert · CGEM

All alert types
14.93 USD -0.10 -0.67%

At close

14.87 -0.06 -0.40%

Pre-market · Nov 3, 8:47 AM ET

Bid
14.92 × 2
Ask
14.93 × 2
14.63 Day range 15.35
6.73 52-week range 23.19
YTD
+44.25%
1 year
+72.40%
Open
15.13
Prev close
15.03
Mkt cap
917.57M
Vol
730.77K
Avg vol
903.67K
EPS
-3.11
P/E
0.00
Div yield
0.00%
More statistics
Low
14.63
High
15.35
Forward P/E
-6.30
Beta
-0.04
Short ratio
6.17
Inst. own
112.54%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
18.28
200-d avg
15.74
1y target
34.60

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 7, 2026Earnings: -0.75; estimate -0.83588; surprise 10.27%
  • Aug 6, 2026Earnings: -0.81; estimate -0.79931; surprise -1.34%
  • Sep 14, 2026Rating: BTIG · Buy → Buy
  • Sep 25, 2026Rating: BTIG · Buy → Buy
  • Sep 25, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 19, 2026Rating: BTIG · Buy → Buy
  • Oct 28, 2026Rating: BTIG · Buy → Buy
Signals (28)
NameDateAgo
MACD: Buy SignalOct 20, 20262 weeks ago
RSI: OversoldOct 16, 20262 weeks ago
RSI: OversoldOct 13, 20263 weeks ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 23, 20261 month ago
RSI: OversoldSep 23, 20261 month ago
MACD: Sell SignalSep 2, 20262 months ago
RSI: OverboughtAug 25, 20262 months ago
RSI: OverboughtAug 17, 20262 months ago
MACD: Buy SignalAug 10, 20262 months ago
SMA: BullishAug 4, 20263 months ago
SMA: BearishAug 3, 20263 months ago
MACD: Sell SignalJul 14, 20263 months ago
RSI: OverboughtJun 25, 20264 months ago
MACD: Buy SignalJun 18, 20264 months ago
SMA: BullishJun 17, 20264 months ago
SMA: BullishJun 17, 20264 months ago
SMA: BearishJun 5, 20265 months ago
SMA: BearishJun 4, 20265 months ago
MACD: Sell SignalJun 4, 20265 months ago

Newest 20 of 28.

Financial health

Altman Z-Score

9.63 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -2.8×
FY 2018: -1.7×FY 2019: -1.5×FY 2020: -25.1×FY 2021: -10.4×FY 2022: 4.3×FY 2023: -2.8×FY 2024: -3.9×FY 2025: -2.8×
FY 2018 5y median -2.8× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 36.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.5×
FY 2018: -1.2×FY 2019: -0.7×FY 2020: 6.5×FY 2021: 1.6×FY 2022: 0.9×FY 2023: 0.9×FY 2024: 1.1×FY 2025: 1.5×
FY 2018 5y median 1.1× FY 2025
P/FCF -3.5×
FY 2018: -1.7×FY 2019: -1.5×FY 2020: -43.7×FY 2021: -15.5×FY 2022: -3.7×FY 2023: -3.1×FY 2024: -4.5×FY 2025: -3.5×
FY 2018 5y median -3.7× FY 2025
EV/EBITDA -2.4×
FY 2018: 0.7×FY 2019: 1.5×FY 2020: -18.8×FY 2021: -9.2×FY 2022: -2.5×FY 2023: -1.7×FY 2024: -3.4×FY 2025: -2.4×
FY 2018 5y median -2.5× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 32.9×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -28.8%
FY 2018: -57.7%FY 2019: -68.8%FY 2020: -2.3%FY 2021: -6.4%FY 2022: -26.8%FY 2023: -31.8%FY 2024: -22.2%FY 2025: -28.8%
FY 2018 5y median -26.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -358.7%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -346.1%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -53.8%
FY 2018: 68.7%FY 2019: 49.1%FY 2020: -26.0%FY 2021: -15.4%FY 2022: 20.8%FY 2023: -33.8%FY 2024: -28.4%FY 2025: -53.8%
FY 2018 5y median -28.4% FY 2025
ROIC -58.7%
FY 2018: -43.8%FY 2019: -22.7%FY 2020: -30.1%FY 2021: -16.0%FY 2022: 19.3%FY 2023: -38.3%FY 2024: -33.2%FY 2025: -58.7%
FY 2018 5y median -33.2% FY 2025
ROA -49.0%
FY 2018: -41.0%FY 2019: -19.9%FY 2020: -24.1%FY 2021: -15.0%FY 2022: 19.8%FY 2023: -31.6%FY 2024: -26.9%FY 2025: -49.0%
FY 2018 5y median -26.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income -22.7%
FY 2018: 0.0%FY 2019: -52.7%FY 2020: -170.9%FY 2021: -12.6%FY 2022: 312.9%FY 2023: -232.1%FY 2024: -3.1%FY 2025: -22.7%
FY 2018 FY 2025
EPS (diluted) -19.6%
FY 2018: 0.0%FY 2019: -10.9%FY 2020: 94.0%FY 2021: -24.4%FY 2022: 260.8%FY 2023: -255.0%FY 2024: 15.7%FY 2025: -19.6%
FY 2018 FY 2025
Free Cash Flow -21.0%
FY 2018: 0.0%FY 2019: -51.5%FY 2020: -42.4%FY 2021: -47.8%FY 2022: -190.3%FY 2023: -5.2%FY 2024: -8.0%FY 2025: -21.0%
FY 2018 FY 2025

Financial Health

Current Ratio 10.2×
FY 2018: 25.8×FY 2019: 39.7×FY 2020: 14.8×FY 2021: 25.2×FY 2022: 21.1×FY 2023: 17.1×FY 2024: 13.5×FY 2025: 10.2×
FY 2018 5y median 17.1× FY 2025
Quick Ratio 10.2×
FY 2018: 25.8×FY 2019: 39.7×FY 2020: 14.8×FY 2021: 25.2×FY 2022: 21.1×FY 2023: 17.1×FY 2024: 13.5×FY 2025: 10.2×
FY 2018 5y median 17.1× FY 2025
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2018: 2.3×FY 2019: 2.8×FY 2020: 2.8×FY 2021: 0.9×FY 2022: 1.1×FY 2023: 0.5×FY 2024: 0.5×FY 2025: 0.4×
FY 2018 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31